Related Experiment Video
Updated: Apr 14, 2026

12:44
Identification of Key Factors Regulating Self-renewal and Differentiation in EML Hematopoietic Precursor Cells by RNA-sequencing Analysis
Published on: November 11, 2014
12.3K
A single workflow for multi-species blood transcriptomics
Elody Orcel1, Hayat Hage1, May Taha1
1BIOASTER, 40 Avenue Tony Garnier, Lyon, 69007, France.
BMC Genomics
|March 17, 2024
Summary
This study introduces a standardized RNA sequencing workflow for blood samples, enabling reliable multi-species transcriptomic analysis for vaccine and drug development. This improves inter-species comparisons and biomarker discovery.
Area of Science:
- Genomics
- Immunology
- Pharmacology
Background:
- Blood transcriptomic analysis offers insights into physiological states and immune responses to vaccines.
- Current multi-species transcriptomic analysis faces technological challenges and lacks standardized workflows for inter-species comparison.
Purpose of the Study:
- To develop a single, comprehensive total RNA sequencing (RNA-Seq) workflow for generating reliable blood transcriptomic data from humans and preclinical animal models.
- To establish standardized criteria and thresholds for validating transcriptomic workflows across species.
Main Methods:
- A complete RNA-Seq workflow was applied to blood samples from humans, rabbits, non-human primates, and mice.
- Workflow performance was rigorously evaluated using multiple wet-lab and dry-lab metrics.
- An automated data analysis pipeline was developed to streamline dataset validation.
Main Results:
- The proposed workflow successfully generated reliable transcriptomic data across four species.
- Key validation criteria and thresholds were identified for assessing workflow performance.
- Automated analysis facilitated efficient validation of generated transcriptomic datasets.
Conclusions:
- An end-to-end workflow was developed to enhance standardization and inter-species comparison in blood transcriptomics.
- This standardized approach allows direct comparison of preclinical and clinical RNA sequencing data for vaccine and drug development.
- The workflow facilitates the identification of biomarkers for monitoring drug safety and vaccine efficacy.

